Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
Clinical trial NCT00333398 · COMPLETED
Trial details
- NCT number
- NCT00333398
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2006-08-01
- Enrollment
- 1359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.